Advanced Human Imaging Limited (AHI)
NASDAQ: AHI · IEX Real-Time Price · USD
1.500
0.00 (0.00%)
Jan 31, 2024, 1:00 AM EDT - Market closed

Company Description

Advanced Health Intelligence Ltd. operates as a mobile application and technology development company in Australia and internationally.

It offers biometric health assessments, a multi-step process that employs facial scanning, heart rate measurements, body composition analysis, and cardiovascular fitness tests that evaluates an individual's health.

The company also provides FaceScan, process that estimates on heart rate, respiration rate, blood pressure, and other through facial scans; BodyScan, a smart body composition and dimensioning technology that enables user to check and assess body dimensions using a smartphone; and DermaScan, a dermatological scanner.

It serves mobile health and telehealth, life and health insurance, wellness, and government sectors. The company was formerly known as Advanced Human Imaging Limited and changed its name to Advanced Health Intelligence Ltd. in December 2022.

Advanced Health Intelligence Ltd. was incorporated in 2014 and is based in South Perth, Australia.

Advanced Human Imaging Limited
Advanced Human Imaging logo
Country Australia
Founded 2013
IPO Date Nov 19, 2021
Industry Software - Application
Sector Technology
Employees 32
CEO Scott Montgomery

Contact Details

Address:
Unit 5/71 - 73 The Esplanade
South Perth, C3 6151
Australia
Phone 61 8 9324 2099
Website advancedhumanimaging.com

Stock Details

Ticker Symbol AHI
Exchange NASDAQ
Fiscal Year July - June
Reporting Currency USD
IPO Price $10.50
CIK Code 0001815436
CUSIP Number 00777C104
ISIN Number US00777C2035
SIC Code 7372

Key Executives

Name Position
Scott Montgomery Chief Executive Officer and Executive Director
Dr. Katherine Iscoe B.A, B.A., M.Sc., MSc, Ph.D. Co-Founder and Executive Director
Simon Durack B.Com., F.C.A., FCIS, J.P. Chief Financial Officer and Company Secretary
Vlado Bosanac Founder and Head of Strategy
Terence Stupple Chief Technology Officer
Riaan Conradie Ph.D. Chief Science Officer
Anita Swan Marketing Director
Nadine Amesz Head of Operations
Kevin Michael Baum Chief Product Officer
Dylan R. Garnett BCom(Hons), BSc(Hons) Chief Innovation Officer

Latest SEC Filings

Date Type Title
Apr 16, 2024 6-K Report of foreign issuer
Jan 18, 2024 UPLOAD Filing
Jan 17, 2024 20-F/A Filing
Jan 5, 2024 6-K Report of foreign issuer
Dec 28, 2023 6-K Report of foreign issuer
Dec 28, 2023 6-K Report of foreign issuer
Dec 18, 2023 UPLOAD Filing
Dec 6, 2023 6-K Report of foreign issuer
Nov 30, 2023 6-K Report of foreign issuer
Nov 29, 2023 6-K Report of foreign issuer